Search
                    Primary Biliary Cholangitis Paid Clinical Trials in Texas
A listing of 5  Primary Biliary Cholangitis  clinical trials  in Texas  actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
            1 - 5 of 5
        
        
    
                The state of Texas currently has 5 active clinical trials seeking participants for Primary Biliary Cholangitis research studies. These trials are conducted in various cities, including Houston, Dallas, San Antonio and Austin. 
            
                                Featured Trial
                
                Healthy Participants Needed (Colonoscopy + Cancer Screening)
            
        Recruiting
            
        Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
    
    
                            Conditions: 
                                    
        
            
                        Healthy
                    
                                    
                        Healthy Volunteers
                    
                                    
                        Healthy Subjects
                    
                                    
                        Healthy Volunteer
                    
                                    
                        Healthy Participants
                    
                                    Featured Offer
                
                Lose Weight with GLP-1 Medications
            
        Recruiting
            
        Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®. 
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
    GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
                            Conditions: 
                                    
        
            
                        Overweight
                    
                                    
                        Overweight and Obesity
                    
                                    
                        Obesity
                    
                                    
                        Weight Loss
                    
                                    
                        Morbid Obesity
                    
                                    Featured Trial
                
                Stroke Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Stroke
    
    
                            Conditions: 
                                    
        
            
                        Stroke
                    
                                    Featured Trial
                
                Chronic Kidney Disease (CKD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Chronic Kidney Disease (CKD)
    
    
                            Conditions: 
                                    
        
            
                        Chronic Kidney Disease (CKD)
                    
                                    Featured Trial
                
                Ischemic heart disease (IHD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Ischemic heart disease (IHD)
    
    
                            Conditions: 
                                    
        
            
                        Ischemic heart disease (IHD)
                    
                                    Featured Trial
                
                Cardiovascular Disease Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Cardiovascular Disease
    
    
                            Conditions: 
                                    
        
            
                        Cardiovascular Disease
                    
                                    
                
                                    A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis
                                
            
            
        Recruiting
                            
            
                The purpose of this clinical research study is to learn more about the use of the study medicine, volixibat, for the treatment of pruritus (itching) associated with Primary Biliary Cholangitis (PBC), and to assess the possible impact on the disease progression of PBC.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                08/21/2025
            
            Locations: Amel Med LLC, Austin, Texas  +3 locations         
        
        
            Conditions: Primary Biliary Cholangitis, PBC
        
            
        
    
                
                                    Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
                                
            
            
        Recruiting
                            
            
                To Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients with Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                08/21/2025
            
            Locations: The Liver Institute at Methodist Dallas Medical Center, Dallas, Texas  +2 locations         
        
        
            Conditions: Primary Biliary Cholangitis
        
            
        
    
                
                                    A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment
                                
            
            
        Recruiting
                            
            
                This study will collect information from participants with Primary Biliary Cholangitis (PBC) as they use the drug elafibranor in real world setting.
PBC is a progressive rare liver disease in which tubes in the liver called bile ducts are damaged.
The liver damage in PBC may lead to scarring (cirrhosis). PBC may also be associated with multiple symptoms including pruritus (itching) and fatigue. Many patients with PBC may require liver transplant or may die if the disease progresses and a liver...  Read More             
        
        
    Gender:
                ALL
            Ages:
                All
            Trial Updated:
                08/14/2025
            
            Locations: Liver Center of Texas, Dallas, Texas  +2 locations         
        
        
            Conditions: Primary Biliary Cholangitis
        
            
        
    
                
                                    A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
                                
            
            
        Recruiting
                            
            
                The participants of this study will have confirmed Primary Biliary Cholangitis (PBC) and cirrhosis (scarring of the liver).
PBC is a slowly progressive disease, characterised by damage to the bile ducts in the liver, leading to a build-up of bile acids which causes further damage.
The liver damage in PBC may lead to cirrhosis. PBC may also be associated with multiple symptoms. Many patients with PBC may require liver transplant or may die if the disease progresses and a liver transplant is not...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                07/29/2025
            
            Locations: Texas Clinical Research Institute, Arlington, Texas  +11 locations         
        
        
            Conditions: Primary Biliary Cholangitis (PBC)
        
            
        
    
                
                                    Open-Label Extension Study of Saroglitazar Magnesium in Participants With Primary Biliary Cholangitis
                                
            
            
        Recruiting
                            
            
                Open-Label Extension Study of Saroglitazar Magnesium in Participants With Primary Biliary Cholangitis             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                05/22/2025
            
            Locations: Zydus US004, Houston, Texas  +1 locations         
        
        
            Conditions: Primary Biliary Cholangitis
        
            
        
    1 - 5 of 5
            
            
        